An interventional study of Vitrectomy with cataract surgery and toric IOL and Vitrectomy with cataract surgery and common IOL in Cataract, Epiretinal Membrane and Corneal Astigmatism, sponsored by Kagawa University. Status unknown at 1 site in Japan. Per ClinicalTrials.gov, last updated 2018-03-07.
Sponsored by Kagawa University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Cataract with a site in Japan — none open to participants now, none under way, none of them phase 3. Cataract · Japan.
Among the 15 studies in Cataract with a site in Japan, this one is the 11th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2015, is one of 11 with no phase, and was the 5th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →None of the 15 studies in Cataract with a site in Japan is open now. The open studies under Cataract, anywhere →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2015.
This study's planned enrollment of 30 is below the median of 79 across 1,094 interventional studies indexed under Cataract.
Median enrollment 61 across the 12 interventional studies, 578 across the 3 observational. Of the 14 that completed or were terminated, 7 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 15 have an industry lead sponsor. The 6 most frequent:
Kagawa University is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
Kagawa University has 1 study filed under Cataract — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Cataract with a site in Japan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Toric intraocular lens (IOL) is now widely used for the cataract surgery with preoperative corneal astigmatism.
Symptomatic epiretinal membrane (ERM) is often treated with 25-gauge transconjunctival sutureless vitrectomy, resulting in good visual recovery. So far, however, limited information is available on the the stability of axis rotation, astigmatism correction, and improvement in uncorrected distance visual acuity, using astigmatism-correcting IOL in a 25-gauge transconjunctival sutureless vitrectomy combined with cataract surgery. In the current study, eyes with a preoperative corneal cylinder of more than 0.75 diopter had a triple procedure for idiopathic ERM using a toric IOL. Outcome measures will be the amount of IOL axis rotation, uncorrected visual acuity, corrected distance visual acuity, and corneal and refractive astigmatism up to 6 months postoperatively. We are expecting to show that postoperative IOL axis stability is similar to that reported for cataract surgery alone in vitrectomy (triple procedure) for idiopathic ERM with a toric IOL.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Eyes that have cataract and ERM with a preoperative corneal cylinder of more than 0.75 diopter.
Device: Vitrectomy with cataract surgery and toric IOL · Device: Vitrectomy with cataract surgery and common IOL
The degree of IOL axis rotation from the end of surgery
Time frame: Six months after the inplantation
The record gives a start of Jan 2015, a primary completion of Oct 2018 and a completion of Oct 2018. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kagawa University